DUBLIN, April 10, 2015 /PRNewswire/ --
Research and Markets(http://www.researchandmarkets.com/research/t5h4lj/global) has announced the addition of the"Global Osteoarthritis Market 2015-2019"report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The Global OA market to grow at a CAGR of 8.55 percent over the period 2014-2019.
OA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, weak thigh muscles, aging, and genetics are some of the common risk factors of OA; OA symptoms usually develop progressively. At first, there may be stiffness that appears to be more a niggle than a medical concern. Treatment is given depending on the affected joint, including the hand, wrist, neck, back, knee, and hip, and involves medication and exercise.
This report covers the present scenario and the growth prospects of the Global OA market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of drugs used in the symptomatic treatment and therapeutics of OA that are available in the market. The market can be divided into three segments: Anti-inflammatories, Pain Relievers, and Drugs to Restore Articular Cartilage.
The presence of several large and small pharmaceutical companies has resulted in intense competition. Many different classes of drugs, such as NSAIDs, simple analgesics, corticosteroids, and opioids that provide effective relief from discomfort in the early-to-mid stages of osteoarthritis are present in the market.
According to the report, certain cellular processes that take place during aging in the human body might contribute to the development of osteoarthritis in some people. As a person ages, the water content of the cartilage increases and the protein makeup of the cartilage degenerates. Thus, an increase in the elderly population drives the market growth.
Further, the report states that many patients do not undergo treatment as they are unaware of the disease and its symptoms. In addition, many others avoid drug therapies owing to their side effects, take medications irregularly, or stop consuming them altogether.
Key Vendors
- Abbott Laboratories
- Johnson & Johnson
- Novartis
- Pfizer
Other Prominent Vendors
- Abiogen Pharma
- Ampio pharmaceuticals
- BioDelivery Sciences International
- CrystalGenomics
- Daiichi Sankyo
- Eli Lilly
- Horizon Pharma
- Iroko Pharmaceuticals
- Merck
- Nuvo Research
- Regeneus
- Sanofi
- SantoSolve
- Smith & Nephew
- Winston Pharmaceuticals
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Introduction
- Disease Overview
- Market Landscape
- Osteoarthritis Pipeline Assessment
- Market Segmentation by Drug Class
- Geographical Segmentation
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Key Vendor Analysis
For more information visithttp://www.researchandmarkets.com/research/t5h4lj/global
Media Contact:Laura Wood , +353-1-481-1716, press@researchandmarkets.net
